Nanochon

Nanochon is a private, pre-revenue medical device company founded in 2015, focused on advancing orthopedic care for cartilage repair. Its core innovation is Chondrograft™, a fully synthetic, 3D-printed implant engineered to mimic natural cartilage's mechanical properties and act as a scaffold for tissue ingrowth. The company is targeting the significant unmet need in treating focal cartilage lesions, aiming to provide a long-term, cost-effective alternative to existing palliative and complex surgical options. Nanochon appears to be in the late pre-clinical or early clinical study phase, as indicated by a referenced research study for an investigational device.

Proprietary synthetic nylon-based composite material engineered to mimic natural cartilage structure, combined with advanced 3D printing to create a load-bearing, porous scaffold that supports tissue regeneration.

Nanochon competes in the cartilage repair market against established cell-based therapies (e.g., MACI), osteochondral allografts, and other synthetic scaffolds. Its primary differentiation is the combination of immediate load-bearing synthetic material with a 3D-printed structure designed for tissue integration, aiming to balance strength and biology more effectively than existing options.